Filing Details
- Accession Number:
- 0001209191-20-050723
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-09-16 17:03:37
- Reporting Period:
- 2020-09-14
- Accepted Time:
- 2020-09-16 17:03:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1403752 | Zymeworks Inc. | ZYME | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1563992 | Diana Hausman | C/O Zymeworks Inc. 1385 West 8Th Avenue, Suite 540 Vancover A1 V6H 3V9 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Acquisiton | 2020-09-14 | 10,000 | $15.74 | 13,718 | No | 4 | M | Direct | |
| Common Shares | Acquisiton | 2020-09-14 | 10,000 | $17.15 | 23,718 | No | 4 | M | Direct | |
| Common Shares | Acquisiton | 2020-09-14 | 10,000 | $9.82 | 33,718 | No | 4 | M | Direct | |
| Common Shares | Acquisiton | 2020-09-14 | 10,000 | $11.84 | 43,718 | No | 4 | M | Direct | |
| Common Shares | Disposition | 2020-09-14 | 40,000 | $45.00 | 3,718 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Shares | Stock Option (Right to Buy) | Disposition | 2020-09-14 | 10,000 | $0.00 | 10,000 | $15.74 |
| Common Shares | Stock Option (Right to Buy) | Disposition | 2020-09-14 | 10,000 | $0.00 | 10,000 | $17.15 |
| Common Shares | Stock Option (Right to Buy) | Disposition | 2020-09-14 | 10,000 | $0.00 | 10,000 | $9.82 |
| Common Shares | Stock Option (Right to Buy) | Disposition | 2020-09-14 | 10,000 | $0.00 | 10,000 | $11.84 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 14,702 | 2017-11-09 | 2026-11-09 | No | 4 | M | Direct |
| 17,235 | 2018-02-03 | 2027-02-03 | No | 4 | M | Direct |
| 75,000 | 2018-06-12 | 2027-06-12 | No | 4 | M | Direct |
| 65,000 | 2019-03-19 | 2028-03-18 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Shares | 2,000 | Indirect | Held by spouse |
Footnotes
- Pursuant to a 10b5-1 plan.
- Based on an exchange rate of US$1.00 to CAD1.3175 as of September 14, 2020.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.0550, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 14, 2020 at each separate price.
- Stock options vest as follows: (i) 25% of underlying shares on first anniversary of grant date and (ii) remainder of underlying shares in 36 equal monthly installments on last day of month following first anniversary of grant date. The grant date was ten years before the listed expiration date.
Billionaire Hedge Funds
